Front Row Advisors LLC Insulet Corp Transaction History
Front Row Advisors LLC
- $277 Million
- Q4 2024
A detailed history of Front Row Advisors LLC transactions in Insulet Corp stock. As of the latest transaction made, Front Row Advisors LLC holds 40 shares of PODD stock, worth $10,825. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 40
-0.0%
Holding current value
$10,825
Previous $9,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PODD
# of Institutions
753Shares Held
63.3MCall Options Held
467KPut Options Held
639K-
Vanguard Group Inc Valley Forge, PA8.49MShares$2.3 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.45MShares$2.02 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.64 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.97MShares$805 Million0.03% of portfolio
-
Baillie Gifford & CO2.36MShares$638 Million0.49% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.8B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...